BI

Biodol

Montpellier, FR · 1 known investors

biodol.eu ↗

Biodol Therapeutics is a biotech company developing proprietary FLT3 inhibitors (BDT compounds) at the preclinical stage to treat neuropathic and chronic pain, including opioid-combination indications. It holds a portfolio of patents covering the use of FLT3 inhibitors for pain treatment.

Investors · 1

V-

V-Bio VenturesGhent · $270K – $2.2M